Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4

Blood

Volumn 114, Issue 23, 2009, Pages 4823-4831

  Milush, Jeffrey M ^a   Long, Brian R ^a   Snyder Cappione, Jennifer E ^a   Cappione III, Amedeo J ^b   York, Vanessa A ^a   Ndhlovu, Lishomwa C ^a   Lanier, Lewis L ^a   Michaëlsson, Jakob ^c   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Guava Technologies   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18 BINDING PROTEIN; CHEMOKINE RECEPTOR; INTERLEUKIN 18; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN K 562; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION; ADULT; ANTIGEN PRESENTATION; CELL GRANULE; CELL SEPARATION; CHEMISTRY; CLASSIFICATION; CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; MIXED LYMPHOCYTE CULTURE; SECRETION;

ADULT; ANTIGEN PRESENTATION; ANTIGENS, CD4; ANTIGENS, CD56; ANTIGENS, CD7; CELL SEPARATION; CYTOPLASMIC GRANULES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; RECEPTORS, CHEMOKINE; RECEPTORS, KIR;

EID: 74049161249     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-216374     Document Type: Article

References (50)

1. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol. 2002;3(1):6-8. (Pubitemid 34065607)
2. Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RA, Roosnek E. Human NK cells can control CMV infection in the absence of T cells. Blood. 2008;112(3):914-915.
3. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220.
4. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol. 2001;1(1):41-49.
5. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol. 2004;5(10):996-1002.
6. Brilot F, Strowig T, Munz C. NK cells interactions with dendritic cells shape innate and adaptive immunity. Front Biosci. 2008;13:6443-6454.
7. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457(7229):557-561.
8. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002;2(11):850-861.
9. Moretta A, Locatelli F, Moretta L. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Immunol Rev. 2008;224:58-69.
10. Walzer T, Blery M, Chaix J, et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci U S A. 2007;104(9):3384-3389.
11. Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461-469.
12. Carlyle JR, Mesci A, Ljutic B, et al. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol. 2006;176(12):7511-7524.
13. Arase H, Saito T, Phillips JH, Lanier LL. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol. 2001;167(3):1141-1144.
14. Hamaguchi-Tsuru E, Nobumoto A, Hirose N, et al. Development and functional analysis of eosinophils from murine embryonic stem cells. Br J Haematol. 2004;124(6):819-827.
15. Slifka MK, Pagarigan RR, Whitton JL. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol. 2000;164(4):2009-2015.
16. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986;136(12):4480-4486.
17. Papewalis C, Jacobs B, Wuttke M, et al. IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol. 2008;180(3):1462-1470.
18. Malmberg KJ, Ljunggren HG. Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. Nat Immunol. 2009;10(1):11-12.
19. Blom B, Spits H. Development of human lymphoid cells. Annu Rev Immunol. 2006;24:287-320.
20. Chicha L, Jarrossay D, Manz MG. Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J Exp Med. 2004;200(11):1519-1524.
21. Spits H, Lanier LL. Natural killer or dendritic: what's in a name? Immunity. 2007;26(1):11-16.
22. Hanna J, Gonen-Gross T, Fitchett J, et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest. 2004;114(11):1612-1623.
23. Roncarolo MG, Bigler M, Haanen JB, et al. Natural killer cell clones can efficiently process and present protein antigens. J Immunol. 1991;147(3):781-787.
24. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol. 2004;173(6):3716-3724.
25. Bernstein HB, Plasterer MC, Schiff SE, Kitchen CM, Kitchen S, Zack JA. CD4 expression on activated NK cells: ligation of CD4 induces cytokine expression and cell migration. J Immunol. 2006;177(6):3669-3676.
26. Harada H, Goto Y, Ohno T, Suzu S, Okada S. Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1. Eur J Immunol. 2007;37(8):2148-2155.
27. Kitchen SG, LaForge S, Patel VP, Kitchen CM, Miceli MC, Zack JA. Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor. Blood. 2002;99(1):207-212.
28. Cutrona G, Leanza N, Ulivi M, et al. Apoptosis induced by crosslinking of CD4 on activated human B cells. Cell Immunol. 1999;193(1):80-89.
29. Wood GS, Warner NL, Warnke RA. Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J Immunol. 1983;131(1):212-216.
30. Hossain M, Okubo Y, Horie S, Sekiguchi M. Analysis of recombinant human tumour necrosis factor-alpha-induced CD4 expression on human eosinophils. Immunology. 1996;88(2):301-307.
31. Biswas P, Mantelli B, Sica A, et al. Expression of CD4 on human peripheral blood neutrophils. Blood. 2003;101(11):4452-4456.
32. Long BR, Ndhlovu LC, Oksenberg JR, et al. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol. 2008;82(10):4785-4792.
33. Meiklejohn DA, Karlsson RK, Karlsson AC, Chapman JM, Nixon DF, Schweighardt B. ELISPOT cell rescue. J Immunol Methods. 2004;288(1-2):135-147.
34. Rabinowich H, Pricop L, Herberman RB, Whiteside TL. Expression and function of CD7 molecule on human natural killer cells. J Immunol. 1994;152(2):517-526.
35. Sempowski GD, Lee DM, Kaufman RE, Haynes BF. Structure and function of the CD7 molecule. Crit Rev Immunol. 1999;19(4):331-348.
36. Mavilio D, Lombardo G, Benjamin J, et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A. 2005;102(8):2886- 2891.
37. Chan CW, Crafton E, Fan HN, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med. 2006;12(2):207-213.
38. Homann D, Jahreis A, Wolfe T, et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity. 2002;16(3):403-415.
39. Pillarisetty VG, Katz SC, Bleier JI, Shah AB, Dematteo RP. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12. J Immunol. 2005;174(5):2612-2618.
40. Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med. 2006;12(2):214-219.
41. Trinité B, Voisine C, Yagita H, Josien R. A subset of cytolytic dendritic cells in rat. J Immunol. 2000;165(8):4202-4208.
42. De Maria A, Fogli M, Costa P, et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol. 2003;33(9):2410-2418.
43. Romero AI, Thoren FB, Brune M, Hellstrand K. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species. Br J Haematol. 2006;132(1):91-98.
44. Vitale C, Chiossone L, Cantoni C, et al. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur J Immunol. 2004;34(11):3028-3038.
45. Schmidt KN, Leung B, Kwong M, et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol. 2004;172(1):138-143.
46. Root LL, Shipley GD. Normal human fibroblasts produce membrane-bound and soluble isoforms of FGFR-1. Mol Cell Biol Res Commun. 2000;3(2):87-97.
47. Chan A, Hong DL, Atzberger A, et al. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol. 2007;179(1):89-94.
48. Lyman SD, Escobar S, Rousseau AM, Armstrong A, Fanslow WC. Identification of CD7 as a cognate of the human K12 (SECTM1) protein. J Biol Chem. 2000;275(5):3431-3437.
49. Pace KE, Lee C, Stewart PL, Baum LG. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol. 1999;163(7):3801-3811.
50. Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol. 2000;165(5):2331-2334.